The International Diabetes Federation (IDF) is drawing up new guidelines for the treatment ... with the latest updates as far as professional education goes. So the goal is that the colleagues ...
Their guidance continues to be a key differentiator between Western New Yorkers living vibrant lives and those struggling. Diabetes is one of the top 10 leading causes of death in the United ...
Richard J. Johnson; Takahiko Nakagawa; L. Gabriela Sanchez-Lozada; Mohamed Shafiu; Shikha Sundaram; Myphuong Le; Takuji Ishimoto; Yuri Y. Sautin; Miguel A. Lanaspa ...
Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...
The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its "calming agent" action in turning off the body's inflammatory response and preventing chronic ...